CardioExchange Archive

September 8th, 2014

Selections from Richard Lehman’s Literature Review: September 8th

Richard Lehman, BM, BCh, MRCGP

This week’s topics include the PARADIGM-HF trial, sham controls in medical-device trials, the efficacy of β blockers in patients with heart failure and atrial fibrillation, and more.

---

September 1st, 2014

Selections from Richard Lehman’s Literature Review: September 1st

Richard Lehman, BM, BCh, MRCGP

This week’s topics include aortic valve stenosis, presenting the benefits of PCI to patients, and more.

---

August 19th, 2014

Increased Cardiac Risk Linked to Clarithromycin

Larry Husten, PHD

Acute use of the popular macrolide antibiotic clarithromycin has been linked to a small but significant increase in cardiac death. In a report in the BMJ, researchers in Denmark analyzed the effects over a 14-year period of the acute use of penicillin V, roxithromycin, and clarithromycin. Earlier research raised concerns that marcrolide antibiotics in general, and erythromycin and azithromycin in […]

---

April 8th, 2013

Selections from Richard Lehman’s Literature Review: April 8th

Richard Lehman, BM, BCh, MRCGP

This week’s topics include an article on open science through data sharing, primary prevention of CVD with a Mediterranean diet, atherosclerosis found in mummies, and more.

---

March 22nd, 2013

Macrolide Antibiotic Linked to Increased CV Risk in Patients with Lung Conditions

Nicholas Downing, MD

Use of the macrolide clarithromycin in patients admitted with exacerbations of chronic obstructive pulmonary disease or community-acquired pneumonia is associated with increased risk for cardiovascular events, a BMJ study finds. Researchers examined outcomes among nearly 3000 patients admitted to U.K. hospitals with either condition. During 1 year of follow-up, there were roughly 450 new admissions for […]

---